Related Experiment Videos
Should beta-blockers be stopped if myocardial ischaemia occurs?
Insights
For patients experiencing myocardial ischemia while on long-term beta-blocker therapy, stopping or continuing the medication showed no significant difference in short-term outcomes. This study suggests beta-blocker management may not alter prognosis in this specific patient group.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Long-term beta-blocker use is common for cardiovascular conditions.
- Myocardial ischemia can occur even in patients on beta-blockers.
- The optimal management of beta-blockers after myocardial ischemia in chronically treated patients is unclear.
Purpose of the Study:
- To investigate the impact of stopping versus continuing beta-blockers in patients with myocardial ischemia.
- To assess the short-term prognosis in chronically beta-blocked patients experiencing myocardial ischemia.
Main Methods:
- Randomized controlled trial involving 56 patients.
- Patients were on long-term beta-blockers and experienced myocardial ischemia.
- Participants were randomized to either stop or continue their beta-blocker medication.
Main Results:
- No significant difference in outcomes between the stop and continue groups.
- Key outcomes assessed included death, heart failure, cardiogenic shock, further ischemia, and arrhythmias.
- The study was limited by its small sample size.
Conclusions:
- Maintaining or stopping beta-blockers after myocardial ischemia did not significantly alter short-term prognosis.
- Evidence from this small series does not support a change in beta-blocker management post-ischemia.
- Further research may be needed to confirm these findings in larger cohorts.
Abstract:
56 patients who were taking a long-term beta-blocker, and in whom myocardial ischaemia occurred, were randomised to stop or to continue the drug. Assessed in terms of deaths, heart failure, cardiogenic shock, further myocardial ischaemia and arrhythmias (except atrial fibrillation), the outcome did not differ significantly in the two groups. We found no evidence in this small series that either maintaining or stopping beta-blockers after an episode of myocardial ischaemia significantly alters the short-term prognosis of chronically beta-blocked patients.